Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1245.50

-24.30 (-1.91%)

< Home < Back

USFDA completes audit at Dr. Reddy's API manufacturing plant

Date: 28-01-2019

USFDA has completed audit at Dr. Reddy's Laboratories’ API manufacturing plant at Miryalaguda in the state of Telangana. The company has been issued with one observation.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.